What type of study is this?

This is a Experimental Study study.

Unwrapping the phytofabrication of bimetallic silver–selenium nanoparticles: Antibacterial, Anti-virulence (Targeting magA and toxA genes), anti-diabetic, antioxidant, anti-ovarian, and anti-prostate cancer activities

View Full Paper

Ask AI

Bookmark

Authors

The research reveals anti-cancer and antibacterial properties of silver–selenium nanoparticles, suggesting potential therapeutic uses.

Ag–Se NPs demonstrated significant antibacterial activity against multiple pathogens, including E. coli and S. aureus.
The nanoparticles showed promising anti-cancer effects, with low IC 50 values of 52.5 and 62.94 μg·mL −1 against prostate and ovarian cancer cells.
Antioxidant assays indicated that Ag–Se NPs surpassed ascorbic acid, showcasing strong antioxidant potential.
The study also highlighted the reduction of virulence gene expression in bacteria, emphasizing the therapeutic prospects of Ag–Se NPs.

Khormi et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

The research reveals anti-cancer and antibacterial properties of silver–selenium nanoparticles, suggesting potential therapeutic uses.

Ag–Se NPs demonstrated significant antibacterial activity against multiple pathogens, including E. coli and S. aureus.
The nanoparticles showed promising anti-cancer effects, with low IC 50 values of 52.5 and 62.94 μg·mL −1 against prostate and ovarian cancer cells.
Antioxidant assays indicated that Ag–Se NPs surpassed ascorbic acid, showcasing strong antioxidant potential.
The study also highlighted the reduction of virulence gene expression in bacteria, emphasizing the therapeutic prospects of Ag–Se NPs.

Khormi et al. (2025) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark